Recruiting

Connect-Home ADRD

Sponsor:

University of North Carolina, Chapel Hill

Code:

NCT06840587

Conditions

Alzheimer Disease

Dementia

Eligibility Criteria

Sex: All

Age: 19+

Healthy Volunteers: Not accepted

Interventions

Connect-Home ADRD

Study Details

Brief summary:

This study is a parallel arm, cluster randomized trial (CRT) to test the efficacy of Connect-Home ADRD, a transitional care intervention focusing on Skilled Nursing Facility (SNF) patients with Alzheimer's disease and dementias and their caregivers during transitions from SNFs to home, assisted, living, and long-term care. The primary hypothesis is that the intervention will reduce caregiver strain (Aim 1) and patient neuropsychiatric symptoms (Aim 2).

Conditions

Alzheimer Disease

Dementia

Study ID

NCT06840587

Start date

Apr 4, 2025

Status verified date

Mar, 2026

Completion date

Jun 30, 2027

Anticipated

Primary completion date

Jun 30, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 19+

Healthy Volunteers: Not accepted

Inclusion Criteria:

Patients:

  • Ability to speak English
  • Goal of discharge to home, assisted living, or long-term care
  • Diagnosis of dementia
  • Having a caregiver willing to participate

Caregivers:

  • Ability to speak English
  • Legally authorized representative (LAR) who also provides support for the person with ADRD

Inclusion criteria for SNFs:

  • Location within 120 miles of UNC-Chapel Hill
  • Admission of at least 75 SNF patients per year

Exclusion Criteria:

Patients:

  • Planned hospital readmission for procedures or treatments within 30 days post enrollment.

Caregivers:

  • LAR is a court-appointed guardian.

Study Design

Enrollment

360 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Supportive Care

Interventions and Outcome Measures

Arms

experimental: Connect-Home ADRD Intervention

The Connect-Home ADRD Intervention will include:

1. Support for SNF staff delivery of transitional care processes including a ADRD transition plan and booklet, caregiver training and engagement, and handoff of care to community providers and Dementia Caregiving Specialist.
2. Support for patients and caregivers provided by the Dementia Caregiving Specialist in three follow-up supportive telephone calls within 30 days of SNF discharge.

no intervention: Standard Care - Control Group

Patient and caregiver dyad randomized to the control arm will receive usual SNF and post-discharge care.

Interventions

Connect-Home ADRD

Connect-Home ADRD will introduce new structure and processes to support SNF staff delivery of transitional care for transitions to home, assisted living, or long-term care, and post-discharge transitional care by the Dementia Caregiving Specialist.

Primary outcome measure

  • Caregiver Strain [ Time Frame: 30 days after discharge from SNF ]
  • Patient Neuropsychiatric Symptoms [ Time Frame: 30 days after discharge from SNF ]

Central Contacts and Locations

Central contacts

Molly Lynch, MS

9198438874molly_lynch@unc.edu

Kathryn Wessell, MPH

919-966-2939kwessell@email.unc.edu

Locations

University of North Carolina at Chapel Hill

Recruiting

Chapel Hill, North Carolina, United States, 27599

Contacts

Molly Lynch, MS

919-843-8874molly_lynch@unc.edu

Mark Toles, PhD, RN

9199665684mtoles@email.unc.edu

More Information

Sponsor

University of North Carolina, Chapel Hill

Last update posted

Mar 30, 2026

Last verified

Mar, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by University of North Carolina, Chapel Hill on 2026-03-30.